Based on the knowledge and experience already gained in the research market (Novartis, Nestlé, GSK,
McMaster University), Motilis improves the management of gastro-intestinal
(GI) patients with
its capsule based device delivering faster and better diagnosis in
a more patient friendly way at reduced costs.
Motilis GI motility monitoring system is based on a magnetic tracking
system (MTS) developed in collaboration with the Swiss Federal Institute
of Technology (EPFL) and the University of Lausanne (UNIL, CHUV).The
first product line (MTS1) was commercialized in 2007 and is used in research
applications. Subsequent R&D led to the second generation product
(MTS2) that will be launched on the clinical market in 2010.
Motilis Medica SA Av. de Cour 48
CH - 1007 Lausanne